共 50 条
- [32] Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive populationBREAST, 2009, 18 : S51 - S51Howell, A.Forbes, J.Cuzick, J.
- [35] Global index to summarise health risks versus benefit in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trialEJC SUPPLEMENTS, 2005, 3 (02): : 98 - 98Howell, A.
- [36] Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerLANCET, 2005, 365 (9453): : 60 - 62Howell, ACuzick, JBaum, MBuzdar, ADowsett, MForbes, JFHoctin-Boes, GHoughton, ILocker, GYTobias, JS
- [37] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopyHUMAN REPRODUCTION, 2005, 20 (01) : 294 - 301Duffy, SJackson, TLLansdown, MPhilips, KWells, MPollard, SClack, GCoibion, MBianco, AR
- [38] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in comhination) trial efficacy and safety update analyses CANCER, 2003, 98 (09) : 1802 - 1810
- [39] Association between prior chemotherapy and the adverse event profile of adjuvant anastrozole and tamoxifen: a retrospective analysis of data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trail on behalf of the ATAC Trialists' GroupANNALS OF ONCOLOGY, 2004, 15 : 64 - 64Coleman, Robert